JON KRUEGER: Open Payments
NPI 1033473749 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$859 in 47 payments from 10 companies in 2025. Trend: 2023 $478 · 2024 $459 · 2025 $859
Food & beverage: $859
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $264 |
| E.R. Squibb & Sons, L.L.C. | 15 | $244 |
| Alkermes, Inc. | 6 | $120 |
| Teva Pharmaceuticals USA, Inc. | 4 | $93 |
| Vanda Pharmaceuticals Inc. | 1 | $36 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
Products named: COBENFY, REXULTI, ARISTADA, ABILIFY MAINTENA, UZEDY, AUSTEDO XR, ABILIFY ASIMTUFII, FANAPT.
Industry payments across MI — which companies pay providers there.
